A Phase III Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception from Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/03 → 11/30/08

Funding

  • Northfield Laboratories: $366,571.00